Guardant Health Inc (OQ:GH)

INK Ultra Money Free

INK Ultra Money Premium

Get a Canadian Insider Club Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • Ad-free browsing
  • INK Ultra Money premium content

(already an Ultra member? Please log into your account for access)

Latest 10 SEC filings (by transaction date) for GH within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 5/19 Dec 3/19 Clark Ian T Direct Ownership STOCK OPTION (RIGHT TO BUY) M - Exercise or conversion exempt under rule 16b-3 -2,690  
Dec 5/19 Dec 3/19 Clark Ian T Direct Ownership COMMON STOCK S - Open market or private sale -2,690 $72.78
Dec 5/19 Dec 3/19 Clark Ian T Direct Ownership COMMON STOCK M - Exercise or conversion exempt under rule 16b-3 2,690 $4.18
Dec 2/19 Nov 27/19 Kaul Samir Indirect Ownership COMMON STOCK J - Other transaction 36,633  
Nov 29/19 Nov 26/19 Talasaz AmirAli Direct Ownership STOCK OPTION (RIGHT TO BUY) M - Exercise or conversion exempt under rule 16b-3 -1,054  
Nov 29/19 Nov 26/19 Talasaz AmirAli Indirect Ownership COMMON STOCK S - Open market or private sale -80 $80.19
Nov 29/19 Nov 26/19 Talasaz AmirAli Indirect Ownership COMMON STOCK S - Open market or private sale -81 $80.19
Nov 29/19 Nov 26/19 Talasaz AmirAli Indirect Ownership COMMON STOCK S - Open market or private sale -2,980 $80.19
Nov 29/19 Nov 26/19 Talasaz AmirAli Direct Ownership COMMON STOCK S - Open market or private sale -1,065 $80.19
Nov 29/19 Nov 26/19 Talasaz AmirAli Direct Ownership COMMON STOCK M - Exercise or conversion exempt under rule 16b-3 1,054 $4.18
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for GH within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 5/19 Dec 3/19 Clark Ian T Direct Ownership STOCK OPTION (RIGHT TO BUY) M - Exercise or conversion exempt under rule 16b-3 -2,690  
Dec 5/19 Dec 3/19 Clark Ian T Direct Ownership COMMON STOCK S - Open market or private sale -2,690 $72.78
Dec 5/19 Dec 3/19 Clark Ian T Direct Ownership COMMON STOCK M - Exercise or conversion exempt under rule 16b-3 2,690 $4.18
Dec 2/19 Nov 27/19 Kaul Samir Indirect Ownership COMMON STOCK J - Other transaction 36,633  
Nov 29/19 Nov 26/19 Talasaz AmirAli Direct Ownership STOCK OPTION (RIGHT TO BUY) M - Exercise or conversion exempt under rule 16b-3 -1,054  
Nov 29/19 Nov 26/19 Talasaz AmirAli Indirect Ownership COMMON STOCK S - Open market or private sale -80 $80.19
Nov 29/19 Nov 26/19 Talasaz AmirAli Indirect Ownership COMMON STOCK S - Open market or private sale -81 $80.19
Nov 29/19 Nov 26/19 Talasaz AmirAli Indirect Ownership COMMON STOCK S - Open market or private sale -2,980 $80.19
Nov 29/19 Nov 26/19 Talasaz AmirAli Direct Ownership COMMON STOCK S - Open market or private sale -1,065 $80.19
Nov 29/19 Nov 26/19 Talasaz AmirAli Direct Ownership COMMON STOCK M - Exercise or conversion exempt under rule 16b-3 1,054 $4.18
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $GH

Competitors

Competitors with Recent Insider Filings
Veracyte (OQ:VCYT)
InVitae (N:NVTA)
Adaptive Biotechnologies (OQ:ADPT)